₹1,090.60
₹-2.80 (-0.26%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹1,549 Cr
P/E
20.94
ROE
5.89%
ROCE
7.50%
About TTK Healthcare Ltd
TTK Healthcare has five main Strategic Business Units namely, Pharmaceuticals (for Animal welfare), Consumer Products, Medical Devices, Foods and Protective Devices Divisions.
Founded
1958
CEO
T T Raghunathan
Employees
3,633
HQ
Chennai, Tamil Nadu
About TTK Healthcare Ltd
TTK Healthcare has five main Strategic Business Units namely, Pharmaceuticals (for Animal welfare), Consumer Products, Medical Devices, Foods and Protective Devices Divisions.
Founded:1958
CEO:T T Raghunathan
Employees:3,633
HQ:Chennai, Tamil Nadu
Finished Products
1Sale of Products
₹2,399.64Cr2discount
₹31.30Cr3Other Operating Revenue
₹11.92CrRaw Materials
1Raw Material Consumed
₹894.83Cr2Purchase of Stock-in-trade
₹886.21CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,217
52W Low
₹735
Volume17.05K
Avg VolumeN/A
Beta0.67
Dividend Yield0.91%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
20.94x
Valuation
P/B Ratio
1.39x
Valuation
EPS
₹52.34
Valuation
Dividend Yield
0.91%
Valuation
ROE
5.89%
Profitability
ROCE
7.50%
Profitability
Revenue by Segment
Contribution & growth by business line
Consumer Products
-1.5%28.1%
₹241.278 Cr
Protective Devices
+4.8%25.3%
₹216.508 Cr
Foods
+13.6%17.6%
₹151.1 Cr
Animal Welfare
+11.6%16.5%
₹141.084 Cr
Medical Devices
+18.6%12.5%
₹106.917 Cr
Others
+11.5%0.0%
₹0.395 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
93.6%
International
6.4%
India93.6%
Outside India6.4%
Strategic Relations
Collaborations, joint ventures & subsidiaries
S
Sara Lee
United States
0.00% stakeL
London International
United Kingdom
0.00% stakeK
Kali Chemi
Germany
0.00% stakeH
Hatu-ICO
Spain
0.00% stakeN
Nicholas Kiwi
United States
0.00% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.02x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
5.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.